Ironwood Pharmaceuticals, Inc. (IRWD) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks

Ironwood Pharmaceuticals, Inc. (IRWD) closed at USD 3.60 on 2026-10-14, a change of +133.8 % over the past year, with a market capitalization of USD 622.95M.

Ironwood Pharmaceuticals, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Ironwood Pharmaceuticals, Inc. key figures

Previous close

USD 3.60 (2026-10-14)

1-year change

+133.8 %

Market cap

USD 622.95M

Enterprise value

USD 940.69M

P/E ratio (trailing)

4.83

P/E ratio (forward)

2.51

EPS (trailing)

0.78

EPS (forward)

1.50

PEG ratio

n/a

Price to book

-3.85

Revenue growth

32.6 %

Earnings growth

125.7 %

Dividend per share (trailing)

0.00

Short ratio

7.79

Employees

100

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It sells linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation, as well as for pediatric patients suffering from functional constipation under the LINZESS and CONSTELLA names. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and Apraglutide, a synthetic peptide long-acting analog of glucagon-like peptide-2 for short bowel syndrome patients dependent on parenteral support, as well as for acute graft versus host disease. It has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Ironwood Pharmaceuticals, Inc. and compare it with other stocks.